Physician profile
Mackenzie Helland
NPI 1508575887
$2,354.54
in general payments reported to CMS, 2019-2025
16 companies · $2,002 in 2025
The $2,002 reported for 2025 was more than what 96% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $353 · 2025: $2,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,118 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,118.04 |
| Education | $236.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $662.97 | 2024-2025 | Interstim |
| Astellas Pharma US INC | $367.12 | 2025 | Xtandi |
| Teleflex LLC | $281.13 | 2024-2025 | Urolift |
| Endo USA, INC. | $190.85 | 2025 | Xiaflex |
| Janssen Biotech, INC. | $189.00 | 2025 | Carvykti, Rybrevant, Erleada |
| Coloplast Corp | $176.13 | 2025 | |
| Ferring Pharmaceuticals INC. | $145.79 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $94.34 | 2024-2025 | Gemtesa |
| Amgen INC. | $90.51 | 2025 | Krystexxa |
| Antares Pharma, INC. | $57.25 | 2024-2025 | Xyosted |
| Verity Pharmaceuticals INC. | $25.93 | 2025 | Tlando |
| C. R. Bard, INC. & Subsidiaries | $18.29 | 2025 | Bard Urinary Drainage Bag |
| Pfizer INC. | $16.34 | 2024 | |
| Olympus America INC. | $15.69 | 2025 | Itind System |
| Tolmar, INC. | $14.07 | 2025 | Jatenzo, Eligard |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9.13 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mackenzie Helland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.